[This review was originally posted at the Nieman Journalism Lab Buy Tramadol No Prescription, on Nov. 4, 2011.]

Should we rethink online paywalls?: It may not be grabbing as many headlines as it was a year ago, but the paid-content train keeps rollin' along, with two more newspapers jumping on board this week: Britain's The Independent is launching a metered paywall for readers outside the U.K. (powered by the Press+ system formerly of Journalism Online), and the Minneapolis Star Tribune is launching a metered model similar to that of the New York Times — 20 free page views a month, Cheap Tramadol no rx, after which the paywall kicks in. Print subscribers will have unlimited access, and the Strib estimates that it'll eventually get $3 million to $4 million in annual revenue from the plan.

On another paywall front, the Lab's Justin Ellis reported that Google, which has been working with publishers on paid content online for a while, has been quietly experimenting with a survey-as-paywall, in which visitors are asked to answer a survey question in order to gain access to the site, japan, craiglist, ebay, overseas, paypal.

This week's quarterly circulation numbers included some positive news about the New York Times' paywall, as Ken Doctor noted at the Lab last week: The New York Times' Sunday circulation actually went up, for the first time in five years, Buy Tramadol No Prescription. Poynter's Rick Edmonds pointed out that this quarter's numbers are the result of a formula in flux, but the good signs have people like NPR's David Folkenflik rethinking the value of online news paywalls.

Not everyone's high on paywalls, of course: After initially being surprised by the high numbers of subscribers to Newsday's online edition, Forbes' Jeff Bercovici found that the number paying for it on its own is still under 1,000. Is Tramadol safe, And GigaOM's Mathew Ingram said that despite its initial success, the Times' paywall is still a stopgap strategy — "an attempt to create the kind of artificial information scarcity that newspapers used to enjoy. And if that is all that newspapers are trying to do, the future looks pretty bleak indeed."

—

Yahoo's new personalized news app: Yahoo jumped into the tablet world this week, announcing the launch of several products for the iPad, including the social TV app IntoNow and Livestand, a "personalized living magazine" (yup, another one), discount Tramadol. Buy Tramadol No Prescription, The obvious point of comparison is Flipboard, and opinions were varied as to how well Livestand compares to Flipboard. Mashable's Ben Parr was pretty impressed, though he noted that Livestand and Flipboard are gathering their content in different ways — Flipboard through your social feeds, and Livestand through its content partners.

Others weren't quite so wowed. Kara Swisher of All Things Digital said Livestand shouldn't be anything new for Flipboard users, and Wired's Tim Carmody saw the difference between Flipboard and Livestand that Parr mentioned as a fundamental error by Yahoo. Tramadol overnight, Flipboard is built for readers, to allow them to distill the good stuff from their social and RSS feeds, he said. But "Yahoo’s Livestand only solves problems for publishers and advertisers: how to display content and advertising to readers without having to have everyone write their own code from scratch." The Lab's Ken Doctor gave several useful areas in which to evaluate Livestand and the coming tablet aggregator wars, Buy Tramadol No Prescription.

Advertising is a big part of what's new with Livestand: With it, they also unveiled Living Ads, which is the latest attempt to create a magazine-like ad on the tablet, using HTML5. As Adweek noted, generic Tramadol, the ads take up a third of the screen and are interactive, with animation and video available. These ads are pretty expensive, but Yahoo's Blake Irving told Business Insider they get advertisers away from the CPM model, which he believes hasn't served advertisers well.

—

Is Assange a step closer to the U.S.?: A week after WikiLeaks announced that it would temporarily shut down to raise money, Tramadol from canada, the whistleblowing website got some more bad news when a British high court ruled that WikiLeaks' founder, Julian Assange, can be extradited to Sweden on charges of sexual assault, rejecting an appeal of a ruling made earlier this year. Buy Tramadol No Prescription, Assange can still appeal to Britain's Supreme Court, but it's headed to Sweden to face trial.

Assange has opposed the extradition to Sweden because he contends that the rulers of that country are aligned against him, but the specter of another extradition is also looming: As Paul Sawers of The Next Web noted, Assange and his supporters are concerned that a move to Sweden would make it much easier for him to be sent to the United States, where the Obama administration and members of Congress have discussed prosecuting him for releasing sensitive information through WikiLeaks, where can i order Tramadol without prescription. Forbes' Andy Greenberg argued, however, that Assange would be more likely to be sent to the U.S. from Britain than from Sweden.

The Associated Press looked at whether WikiLeaks could survive Assange's extradition — its answer: probably not — and Swedish columnist Karin Olsson wrote in the Guardian that Assange has lost all of his intriguing man-of-mystery status in her country. But Australian journalist Matt da Silva urged people not to let up in their support of Assange, praising him as a crusader against government's efforts to manage and control the media, Buy Tramadol No Prescription.

—

Reconciling journalism and political views: What started a couple of weeks ago as yet another public radio conundrum regarding its employees and political opinions morphed into an interesting discussion about journalism and transparency. My Tramadol experience, Two public radio employees, Lisa Simeone of Soundprint and Caitlin Curran of WYNC's The Takeaway, were fired after taking part in Occupy Wall Street protests. Curran told her story at Gawker, and Brooke Gladstone, host of the NPR show On the Media, discussed NPR's policy in a live chat.

The Atlantic's Conor Friedersdorf argued that WNYC was wrong to fire Curran, buy Tramadol without prescription, pointing out that several NPR reporters have made essentially the same point she did in her protest sign, and have been praised for it. He and the Guardian's Dan Gillmor also made the case Buy Tramadol No Prescription, for doing away with the philosophy of viewlessness in the American press. As Gillmor put it, telling journalists they can't even hint at what they believe "puts a barrier between them and their audiences – a serious problem given that news and journalism are evolving from a lecture into a conversation." Though he wasn't discussing the public radio firings, Gawker's Hamilton Nolan did provide a counterargument, defending journalistic facelessness and an institutional writing style. Tramadol trusted pharmacy reviews, And as if on cue, former New York Sun editor Ira Stoll launched News Transparency, a site that lets people know about journalists' backgrounds as a kind of imposed transparency from the outside, as Poynter's Jeff Sonderman put it.

—

The Verge takes off: A new tech blog to watch: The sports blog network SB Nation launched a tech blog called The Verge this week, under the leadership of several former Engadget staffers. As part of the launch, SB Nation and The Verge will both fall under a new parent media called Vox Media, where can i buy cheapest Tramadol online. The site got some initial rave reviews over its updating story streams, something that SB Nation has been using for a while, Buy Tramadol No Prescription.

Business Insider has an interview with the folks behind the site, and the Lab's Justin Ellis talked about where SB Nation/Vox will go from here. The Lab's Joshua Benton also pulled three lessons for news orgs out of the site's development, emphasizing bold, tablet-style design, structured data, Tramadol class, and community.

—

Reading roundup: Tons of stuff going on this week. Here's the TL;DR version of the rest:

— Google began giving journalists photos next to their stories in Google News — but only if they have a Google+ account. Alexander Howard was OK with it Buy Tramadol No Prescription, , but Columbia's Emily Bell wasn't, calling it coercion and saying it only helped Google, not journalism.

— The St. Petersburg Times, a newspaper owned by the nonprofit Poynter Institute, announced it will change its name to the Tampa Bay Times on Jan. 1, order Tramadol online c.o.d, broadening its geographic focus. Poynter rounded up some of the reaction on social media and compared the decision to other recent newspaper name changes.

— Your weekly News Corp, Buy Tramadol No Prescription. phone hacking update: New documents released by a committee of Britain's Parliament revealed that a company attorney warned of a culture of hacking back in 2008. Here's the summary from News Corp.'s own Wall Street Journal and a blow-by-blow from the Guardian.

— As GigaOM's Colleen Taylor reported, Twitter has quietly unveiled new Top News and Top People search functions. Tramadol photos, Poynter's Jeff Sonderman looked at the effect it will have on publishers.

— Media analyst Frederic Filloux examined the sad state of web news design, and Amy Gahran of the Knight Digital Media Center said all the ugliness could help push users to the mobile web.

— The Guardian launched n0tice, their open community news platform. The Lab's Megan Garber took a look at the new site, and The Next Web's Martin Bryant examined it as a possible replacement for local newspapers.

— Finally, here's hoping this inspiring Lab post by Jacob Harris will forever put an end to the insipid question, "Will X save journalism?".

Similar posts: Order Cipro. Zoloft Price. Tramadol Mg. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Buy Tramadol No Prescription. Buy Tramadol No Prescription. Buy Tramadol No Prescription. Where to buy Tramadol. Canada, mexico, india. Tramadol forum.

Order Cephalexin, [This review was originally posted on Oct. 7, 2011, at the Nieman Journalism Lab.]

A man who thought different: The tech, media, and business worlds lost one of their brightest minds this week: Steve Jobs, Cephalexin pics, the visionary who co-founded Apple and helped transform virtually every industry this site touches on, died Wednesday at age 56. Thousands of people have been pouring out their thanks and remembrances online over the past couple of days; I'll try to highlight some of the most insightful reflections here.

First, the obituaries: The New York Times and Wall Street Journal memorialized Jobs in their formal, definitive style, while Wired's Steven Levy took a more interpretive angle on Jobs' life and work, order Cephalexin from mexican pharmacy. The Times offered a fantastic interactive guide to Jobs' 317 patents, and All Things Digital remembered Jobs with a collection of his own words. One of his most well-known public statements is a 2005 commencement speech that included some profound thoughts about death, including the statement, "Your time is limited, so don’t waste it living someone else’s life."

The New York Times and the Lab's Megan Garber have good summaries of the ways people remembered and honored Jobs on Wednesday, Order Cephalexin. Several pieces on Jobs' legacy, by the LA Times' Michael Hiltzik, Slate's Farhad Manjoo, and Reuters' Kevin Kelleher, centered on a similar point: Jobs' expertise wasn't in technical advancements so much as it was in his uncanny ability to recognize what made technologies frustrating for people to use and then to develop brilliant solution after brilliant solution. As the AP's Ted Anthony put it, "He realized what we wanted before we understood it ourselves."

Others remembered Jobs for what tech blogger Dave Winer called "the integrity of his vision." For the Atlantic's Alexis Madrigal, that vision meant a distinctive devotion to work for pure self-fulfillment, Cephalexin images, and that devotion led to, as Richard MacManus of ReadWriteWeb pointed out, a corporate culture uniquely predicated on accountability and direct responsibility. Berkman Center fellow Doc Searls brought up some old insights about Jobs' dedication to innovation, and at the Guardian, Cephalexin no rx, Dan Gillmor wrote on the juxtaposition between his awe of Jobs' genius and his concern about Apple's growing control.

A few people looked specifically at Steve Jobs' impact on the media industry — GigaOM's Mathew Ingram looked at the ways Apple has continued to disrupt media, especially with the iPhone, which definitively turned the phone into a media consumption device. Jeff Sonderman of Poynter republished a piece on Jobs' relationship with the news industry, and the New York Times' David Carr said Jobs made business journalism cool for the first time.

Then there were the personal stories: Fast Company collected bunches of accounts Order Cephalexin, of tech execs, writers, and students' first meetings with Jobs, and the Wall Street Journal's Walt Mossberg shared several Jobs stories of his own. Tech blogger John Gruber wrote on the grass-stained sneakers Jobs wore to his keynote address at a conference in June — "the product of limited time, buy cheap Cephalexin, well spent." And former Gizmodo writer Brian Lam, who had a notorious run-in with Apple last year over a lost iPhone prototype, reflected on Jobs' kindness and forgiveness amid that incident.

—

Two media giants jump in together: ABC News and Yahoo announced a major partnership for online news, agreeing to share web content, Cephalexin price, coupon, count traffic together, and produce web video series. It's not a full-fledged merger: The two organizations will remain independent, but they'll share news bureaus and sell ads together as ABC produces web series for Yahoo and Yahoo maintains the web operations of shows like 'Good Morning America.'

These two companies have done something like this before — as Poynter noted, their announcement this week was strikingly similar to an announcement between the two orgs back in 2000. Still, the New York Times said it's the deepest partnership of its kind since NBC and Microsoft in the mid-'90s, Cephalexin schedule. The basic reasons for the move seem to make sense: As the Times and TV Newser pointed out, ABC News has plenty of corporate muscle behind it via Disney, but has lagged behind its competitors in web traffic, Order Cephalexin. Yahoo, on the other hand, is swimming in traffic but has had some serious difficulty figuring where to go from there.

Still, the deal got a lukewarm reception from many online media analysts. Cephalexin from canadian pharmacy, One of them told Ad Age that for ABC News, Yahoo was "the last life vest on the Titanic." Wired's Tim Carmody said ABC and Yahoo could have some quite interesting opportunities for cooperation, but instead, they're "both left chasing The Huffington Post — a fast-growing, web-native and increasingly multimedia-savvy and professional-journalism-driven site." Mathew Ingram of GigaOM described the move as a doomed, retrograde portal strategy: What these organizations need, he said, order Cephalexin no prescription, is not more eyeballs, but more targeted audiences and well-produced niche content.

But here at the Lab, media prof Josh Braun said that while the partnership is far from a slam dunk, it's still an ambitious move with the potential of giving ABC News a foothold into round-the-clock content and some demographic niches highly coveted by advertisers. Order Cephalexin, On Yahoo's side, Forbes' Jeff Bercovici wondered if they're moving away from producing original content. Doses Cephalexin work, —

Apple drops the next iPhone: The news of Steve Jobs' death dwarfed what had been a significant development for Apple-philes: The unveiling earlier this week of the next iteration of the iPhone, the iPhone 4S. As the New York Times explained, the new iPhone doesn't look much different from the current one, but most of its improvements below the surface, most notably in adding a voice-activated personal assistant named Siri.

This was not what everyone was expecting; for weeks, Cephalexin long term, the tech press had wrongly predicted an iPhone 5, only to see upgrades that were smaller and more incremental than they expected. The result was disappointment for many, summed up well by Henry Blodget of Business Insider and Farhad Manjoo of Slate. Others, like tech writer Dan Frommer and the New York Times' Nick Bilton, said there was plenty to like about the iPhone 4S, including faster download speeds and a more powerful camera, Order Cephalexin.

Poynter's Jeff Sonderman looked at several aspects of the new iPhone of interest to journalists, Cephalexin interactions, focusing specifically on Apple's new Newsstand section for newspaper and magazine apps. He expressed some concern that the Newsstand locks publishers into Apple's 30-percent-cut pay system while duplicating the old print news-buying experience, rather than creating something new.

—

Reading roundup: This week was a busy one outside of the big stories, too. Here's what else people were talking about:

— Some conversation that continues to trickle out about Facebook's overhaul: GigaOM's Mathew Ingram argued that Facebook's "frictionless sharing" is where the web is headed next, the Lab's Ken Doctor and Gina Chen looked at what's in this for news orgs, Cephalexin street price, and at the Atlantic, Ben Zimmer looked at what Facebook has done to the way we use language. Order Cephalexin, — Commentary about last week's Kindle announcement also continued this week, with Frederic Filloux explaining why he's excited about the Kindle Fire's potential for news media and magazine publishers saying the Fire could help spark some big revenue in tablets. Meanwhile, Nate Hoffelder noted that there's a lot that you can't do with the Kindle and its apps, and Mathew Ingram wondered what will happen to the book industry when Kindle prices drop to zero. Cephalexin cost, — Jonathan Stray's thoughtful post a couple of weeks ago about journalism for makers has led to a slow-burning discussion: Grad student Blair Hickman proposed a model for solution-based journalism, while j-prof C.W. Anderson questioned whether journalists have the authority for such an approach. Meanwhile, Josh Stearns of Free Press mused on applying "systems thinking" to journalism.

— This month's Carnival of Journalism produced a solid set of posts that examined a variety of aspects of online video, from technique to philosophy to business, Order Cephalexin. Here's the roundup.

— Two useful pieces of advice from Poynter: A guide for news sites to partnering with local blogs, and for journalists to getting started with data journalism.

— Former New York Times editor Bill Keller offered a (surprisingly) bullish take on the potential for a sustainable business model in online news, and the Center for Investigative Reporting's Robert Rosenthal gave a thorough up-close look at what that means for a single news org in his four-part report on making CIR and California Watch sustainable. Here's part one and the bullet-point version.

Similar posts: Retin A Cost. Lipitor Over The Counter. Zoloft Over The Counter. Order Diflucan from United States pharmacy. Tramadol from mexico. No prescription Tramadol online.
Trackbacks from: Order Cephalexin. Order Cephalexin. Order Cephalexin. Doses Cephalexin work. Cephalexin long term. Cephalexin results.

[This review was originally posted at the Nieman Journalism Lab Cipro Dosage, on Sept. 16, 2011.]

Paid and free, side by side: The Boston Globe became the latest news organization to institute an online paywall this week, but it did so in an unprecedented way that should be interesting to watch: The newspaper created a separate paid site, BostonGlobe.com, Order Cipro from United States pharmacy, to run alongside its existing free site, Boston.com. PaidContent has the pertinent details: A single price ($3.99 a week), and Boston.com gets most of the breaking news and sports, while BostonGlobe.com gets most of the newspaper content. The Lab's Justin Ellis, meanwhile, buy no prescription Cipro online, has a look at the lab that designed it all.

As the Globe told Poynter's Jeff Sonderman, the two sites were designed with two different types of readers in mind: One who has a deep appreciation for in-depth journalism and likes to read stories start-to-finish, and another who reads news casually and briefly and may be more concerned about entertainment or basic information than journalism per se.

The first thing that caught many people's attention was new site's design — simple, clean, and understated, Cipro Dosage. Tech blogger John Gruber gave it a thumbs-up, Buy Cipro without prescription, and news design guru Mario Garcia called it "probably the most significant new website design in a long time." The Lab's Joshua Benton identified the biggest reasons it looks so clean: Far fewer links and ads.

Benton (in the most comprehensive post on the new site) also emphasized a less noticeable but equally important aspect of BostonGlobe.com's design: It adjusts to fit just about any browser size, which eliminates the need for mobile apps, making life easier for programmers and, as j-prof Dan Kennedy noted at the Lab, a way around the cut of app fees required by Apple and others. If the Globe's people "have figured out a way not to share their hard-earned revenues with gatekeepers such as Apple and Amazon, then they will have truly performed a service for the news business — and for journalism, Cipro trusted pharmacy reviews," Kennedy said.

Of course, the Globe could launch the most brilliantly conceived news site on the web, but it won't be a success unless enough people pay for it. Poynter's Sonderman (like Kennedy) was skeptical of their ability to do that, Ordering Cipro online, though as the Atlantic's Rebecca Rosen pointed out, the Globe's plan may be aimed as much at retaining print subscribers as making money off the web. The Washington Post's Erik Wemple wondered Cipro Dosage, if readers will find enough at BostonGlobe.com that's not at Boston.com to make the site worth their money.

—

The TechCrunch conflict and changing ethical standards: Last week's flap between AOL and TechCrunch over the tech site's ethical conflicts came to an official resolution on Monday, when TechCrunch founder Michael Arrington parted ways with AOL, the site's owner. But its full effects are going to be rippling for quite a while: Gawker's Ryan Tate called the fiasco a black eye for everyone involved, but especially AOL, Cipro samples, which had approved Arrington's investments in some of the companies he covers just a few months ago. Fellow media mogul Barry Diller also ripped AOL's handling of the situation.

At the Guardian, Dan Gillmor said that while he doesn't trust TechCrunch much personally, it's the audience's job to sort out their trust with the help of transparency, Cipro recreational, rather than traditional journalism's strictures. Others placed more of the blame on TechCrunch: Former Newsweek tech editor Dan Lyons said TechCrunch's people should have expected this type of scenario when they sold to a big corporation, and media analyst Frederic Filloux said TechCrunch is a perfect example of the blogosphere's vulnerability to unchecked conflicts of interest.

There was more fuel for those kinds of ethical concerns this week, as the winning company at TechCrunch's annual Disrupt competition was one that Arrington invests in, Cipro Dosage. But Arrington had an ethical accusation of his own to make at the conference, pointing out that the New York Times invests in a tech venture capital fund which has put $3.5 million into GigaOM, a TechCrunch competitor. Poynter's Steve Myers detailed the Times' run-ins between the companies it invests in and the ones it covers (and its spotty disclosure about those connections), concluding that even if the conflict is less direct than in blogging, comprar en línea Cipro, comprar Cipro baratos, it's still worth examining more closely.

As it plunged further into its battle with TechCrunch late last week, AOL was also reported to be talking with Yahoo, which recently fired its CEO, about a merger between the two Internet giants. Cheap Cipro no rx, All Things Digital's Kara Swisher said there's no way the deal would actually happen, and Wired's Tim Carmody called it a "spectacularly crazy idea" and GigaOM's Mathew Ingram agreed, while Business Insider reminded us that they said a year ago that AOL and Yahoo should merge. Cipro Dosage, Meanwhile, the New York Times' David Carr homed in on the core problem that both companies are facing: The fact that people want information online from niche sites, not giant general-news portals. "As news surges on the Web, giant ocean liners like AOL and Yahoo are being outmaneuvered by the speedboats zipping around them, relatively small sites that have passionate audiences and sharply focused information," he wrote.

—

Facebook opens to subscribers: It hasn't gotten nearly as much attention as some of its other moves, but Facebook took another step in Twitter's direction this week by introducing the Subscribe Button, which allows users to see other people's (and groups') status updates without friending or becoming a fan of them.

As GeekWire's Monica Guzman and many others noted, buy cheap Cipro no rx, Facebook's "subscribe" looks a heck of a lot like Twitter's "follow." When asked about similar Google+ features at the TechCrunch Disrupt conference, a Facebook exec said it wasn't a response to Google+.

Guzman said Facebook is putting down deeper roots by going beyond the limits of reciprocal friendship, and GigaOM's Mathew Ingrampinpointed the reason why this could end up being a massive change for Facebook: It's beginning to move Facebook from a symmetrical network to an asymmetrical one, which could fundamentally transform its dynamics. Still, Cipro brand name, Ingram said Twitter is much better oriented toward being an information network than Facebook is, even with a "Subscribe" button.

The change could have particularly interesting implications for journalists, as Poynter's Jeff Sonderman explained in his brief outline of the feature. As he noted, it may eliminate the need for separate Facebook profiles and pages for journalists, and while Lost Remote's Cory Bergman said that should be a welcome change for journalists who were trying to manage both, he noted that shows and organizations may want to stick with pages, Cipro Dosage.

—

News Corp.'s scandal widens: An update on the ongoing scandal enveloping News Corp.: A group of U.S. banks and investment funds that own shares in News Corp. expanded a lawsuit to include allegations of stealing, hacking, purchase Cipro for sale, and anti-competitive behavior by two of the company's U.S. subsidiaries — an advertiser and a satellite TV hardware manufacturer. As the Washington Post's Erik Wemple noted, these are old cases, but they're getting fresh attention, Cipro dosage, and that's how scandals gain momentum. Cipro Dosage, James Murdoch, the son of News Corp.'s Rupert Murdoch, was also recalled to testify again before members of Britain's Parliament later this fall, facing new questions about the breadth of News Corp.'s phone hacking scandal. The Wall Street Journal examined the scandal's impact on the elder Murdoch's succession plan for the conglomerate, especially as it involves James. The company's executives also announced this week that they've found tens of thousands of documents that could shed more light on the phone hacking cases.

—

Reading roundup: Here's what else went on this week:

— The biggest news story this week, of course, is actually 10 years old: Here's a look at how newspapers marked the anniversary of 9/11, real brand Cipro online, how news orgs used digital technology to tell the story, and a reflection on how 9/11 changed the media landscape.

— Twitter introduced a new web analytics tool to measure Twitter's impact on websites. Here's an analysis from Mathew Ingram of GigaOM, Cipro Dosage.

— At an academic conference last weekend, Illinois j-prof Robert McChesney repeated his call for public funding for journalism. Purchase Cipro online no prescription, Here are a couple of good summaries of his talk from fellow j-profs Axel Bruns and Alfred Hermida.

— Finally, here's a relatively short but insightful two-part interview between two digital media luminaries, Henry Jenkins and Dan Gillmor, about media literacy, citizen journalism and Gillmor's latest book. Should make for a quick, thought-provoking weekend read.

Similar posts: Lipitor Price. Flagyl For Sale. Bactrim Mg. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Cipro Dosage. Cipro Dosage. Cipro Dosage. Cheap Cipro no rx. Cipro dose. Buy Cipro online cod.

[This review was originally posted at the Nieman Journalism Lab Order Glucophage, on Sept. 9, 2011.]

TechCrunch, ethics, and new notions of journalism: The prominent tech news site TechCrunch tends to find itself in the middle of some controversy or another fairly regularly. Usually they're relatively inconsequential inside baseball, but this week's blowup is by far its biggest, and it spurred some enlightening discussion outside of the tech-news bubble, canada, mexico, india.

Here's the quick summary of what happened (the Guardian has a fuller version): Michael Arrington, TechCrunch's founder and editor, launched a venture capital fund to invest in tech companies — the same companies TechCrunch covers. AOL, which bought the site last year, responded by taking him off of TechCrunch and moving him to the business side in an arrangement that no one completely understood. Arrington fired back with an ultimatum: Give TechCrunch total editorial freedom, or sell it back to him, Order Glucophage. Effects of Glucophage, AOL has reportedly countered by booting Arrington entirely. Whatever happens, TechCrunch's MG Siegler said the site won't likely be the same.

There were conflicting views on the impact of Arrington's reported ouster, of course — Reuters' Felix Salmon said AOL is losing its top journalist, while Fortune's Chadwick Matlin said the fall of TechCrunch would be good for the tech industry. But the central issue here was the ethics of Arrington's arrangement — investing in the same companies his site covers, something he's been doing openly for years, real brand Glucophage online.

The critique was articulated most strongly by the New York Times' David Carr Order Glucophage, , who documented several instances of TechCrunch writing favorable pieces on companies in which Arrington had invested, calling the arrangement "almost comically over the line." All Things Digital's Kara Swisher delivered an angrier version — "A giant, greedy, Silicon Valley pig pile" — and many others were also critical, including the Atlantic's Alexis Madrigal, Rem Rieder of the American Journalism Review, and VentureBeat's Dylan Tweney.

TechCrunch had its defenders, too, including Gawker's Ryan Tate, who argued for the hypocrisy of AOL's Arianna Huffington's sudden concern about ethics. The most thorough defenses, though, Glucophage coupon, came from TechCrunch's writers themselves: First, Paul Carr asserted that the new company would have nothing to do with TechCrunch. Then, both Carr and MG Siegler responded to David Carr's column by arguing that their site doesn't have the editorial workflow that its critics assume, and by criticizing the Times for its own ethical conflicts. "Ultimately there is only one thing that matters: information. People don’t care how they get it, just that they get it. If they don’t think they can trust it from one source, they’ll find another way to get it," Siegler wrote, Order Glucophage.

Some observers, buy cheap Glucophage no rx, like New York mag's Chris Rovzar, called that defense naive. In a terrific post here at the Lab, j-prof C.W. Anderson looked a bit deeper into the ways TechCrunch's philosophy challenges traditional journalism's norms, particularly the site's commitment to transparency as its primary ethical safeguard and its idea of the supremacy of information. About Glucophage, There was also the question of whether Arrington should have to abide by journalistic standards in the first place. Arrington asserted Order Glucophage, that he's not a journalist, and tech pioneer Dave Winer argued that "journalism itself is becoming obsolete." GigaOM's Mathew Ingram countered that journalism is still alive, just evolving and expanding, and j-prof Jeff Jarvis said journalism defies definition, and that's just fine.

—

A bigger challenge for Digital First: John Paton has grabbed a lot of attention with his rejuvenation of the formerly bankrupt newspaper chain the Journal Register Co., and this week, his project expanded to include a much larger (also formerly bankrupt) company, MediaNews Group, which owns papers such as the Denver Post, St. Paul Pioneer Press, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release, and Detroit News. Though the two companies will remain formally separate, Paton will manage both companies under the auspices of the newly created Digital First Media.

Paton briefly reiterated his digitally centered philosophy in a blog post on the move, and GigaOM's Mathew Ingram called him the "patron saint" of the digitally focused, open approach to newspapers, Buy Glucophage no prescription, as opposed to the more print-protectionist, paywall-oriented one. Reuters' Felix Salmon said Paton's model of leveraging local sales staff and trusted editorial content for digital revenue makes much more sense than the hyperlocal-en-masse Patch model, Order Glucophage.

There's another important aspect to this deal, though: the Journal Register Co. was bought this summer by Alden Global Capital, a hedge fund that also owns a significant stake in MediaNews and several other newspaper companies. The Lab's Joshua Benton provided some background on that situation, and Ken Doctor predicted that the move "may mark just the beginning of a local newspaper roll-up, Glucophage cost, resulting in the United States’ first truly national local news(paper) company," noting that Paton's Digital First initiative is also accompanied by major cost-cutting. At the Knight Digital Media Center, Amy Gahran expressed concern that Paton's plans could run aground on an entrenched traditional culture at MediaNews and the impatience of hedge-fund investors. Order Glucophage, MediaNews also has newly installed paywalls at 23 papers, and Paton told paidContent he isn't sure yet what will happen to them. But one change has already been made: MediaNews' contract with copyright litigant Righthaven has been ended.

—

WikiLeaks under fire: We talked last week about the inadvertent release of the rest of WikiLeaks' archive of 251, Glucophage pharmacy, 000 diplomatic cables and the fallout that ensued. As it happened, WikiLeaks decided late last week to go ahead and publish all of the unredacted cables themselves, given that they had already been leaked online.

The decision led to more criticism — not just from the traditional media, but from others on the web: the Personal Democracy Forum's Micah Sifry, author of a book on WikiLeaks, chastised the organization for the dump, online buy Glucophage without a prescription, saying it's thrown away the moral high ground. Consultant Tom Watson said WikiLeaks' move has damaged their efforts at transparency and an empowered society, and James Ball, a former WikiLeaks volunteer, made the same point more powerfully by painting a picture of an internal culture at odds with the group's stated ideals of accountability and openness. "WikiLeaks has done the cause of internet freedom – and of whistleblowers – more harm than US government crackdowns ever could," he said, Order Glucophage.

Tech blogger Dave Winer, however, After Glucophage, was more troubled by the traditional media's eagerness to blame and ostracize Assange for the incident. It's not about one person, he said, it's about the technology that makes WikiLeaks possible: "They have a method that they have religious feelings about, ones that some of us don't share, and that method is broken by the Wikileaks model." Mediaite's Frances Martel, meanwhile, wondered why no one seemed to care about the documents themselves, herbal Glucophage.

—

Yahoo fires its CEO: After a tumultuous two-and-a-half-year tenure, Yahoo CEO Carol Bartz was fired this week. The next step for the troubled Internet giant could be to engineer a sale, as CNNMoney's Paul La Monica urged it to do. Order Glucophage, Plenty of names were tossed around as potential buyers, most recently Yahoo co-founder Jerry Yang.

The Wall Street Journal detailed what's gone wrong at Yahoo, and Om Malik of GigaOM was one of many who pinned many of the company's failings on its board. Glucophage reviews, Malik called for Yahoo to rid itself of everything that connects it to the Internet's past, and Business Insider's Pascal-Emmanuel Gobry advised Yahoo to "own the fact that it's a media and content company," encouraging a strategy that looks quite similar to AOL's. PaidContent's David Kaplan noted that Yahoo has a lot of ground to make up in display advertising, and Mark Walsh of MediaPost wondered if we'll see more of an emphasis on mobile media from Yahoo now.

—

Reading roundup: Just a couple more items for this week:

— One piece of news to note: Google has killed FastFlip, the magazine-like news presentation tool it launched in 2009.

— As we continue to move closer to bona fide campaign season, Glucophage maximum dosage, the Columbia Journalism Review's Greg Marx offered a smart response to Jay Rosen's critique of political journalism last week, defending the usefulness of certain kinds of the much-maligned "horse-race journalism."

— On the practical side, Florida j-prof Mindy McAdams put together a handy list of 10 tips to compelling visual storytelling. It's a great resource for professionals, j-profs, and students.

Similar posts: Lipitor Cost. Cephalexin No Rx. Buy Retin A No Prescription. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Order Glucophage. Order Glucophage. Order Glucophage. Order Glucophage online overnight delivery no prescription. Buy Glucophage online no prescription. Glucophage price, coupon.

[This review was originally posted at the Nieman Journalism Lab Buy Glucophage No Prescription, on Nov. 19, 2010.]

An unpopular marriage: As I briefly noted in last week's review, the big story this week was, not surprisingly, Newsweek's merger with Tina Brown and Barry Diller's website The Daily Beast. The New York Observer, which broke the story, buying Glucophage online over the counter, had most of the newsy details — merged websites under The Daily Beast, unspecified layoffs to come, etc. — as well as the story of how the deal went down.

The Daily Beast's own Howard Kurtz had some notes on what the new organization would look like, led by Brown's assertion that whatever the new Newsweek will be, Glucophage recreational, it won't be the newsmagazine format. As The New York Times' Evelyn Rusli observed, the key asset in this deal may not be either property but instead Brown, one of the U.S.' most prominent magazine editors, Buy Glucophage No Prescription. The Wall Street Journal had more notes on Brown, and Slate's Jack Shafer dished out some advice for her.

Just about the only media figure who voiced any sort of excitement about the deal was Arianna Huffington; everyone else's responses ranged from indifference to revulsion. The New York Times' David Carr laid his derision on thick, saying the deal "marries two properties that have almost nothing in common other than the fact that they both lose lots of money." NYU professor Clay Shirky called it a farcical reprise of the AOL-Time Warner bomb. TechCrunch's Erick Schonfeld warned the two companies not to combine their brands (and it appears they won't, except online), Glucophage without prescription.

The Wall Street Journal summed up the doubters' concerns well with a list of four reasons Buy Glucophage No Prescription, for concern: Joint ventures are tough, media joint ventures are tougher, it's headed by strong-willed personalities, and it's a merger of two companies that are losing money. The last point gained the most traction, building on media reports (which Scott Rosenberg questioned) that have Newsweek on pace to lose $20 million this year and The Daily Beast on track to lose $10 million (though it was supposedly expected to turn a profit within two years). Business Insider's Henry Blodget joined the Journal in wondering how they'd make money together, and Forbes' Jeff Bercovici asked a good question: If your media venture is on track to profitability, why would you want to tie yourself to a business that's gone nowhere but down?

There were a couple of possible answers: First, as The New York Times reported, Glucophage price, the Beast's Diller has developed a sudden affinity for print publications. Also, Mediaite's Colby Hall noted that with as much content as the Beast produces, Newsweek's costs could drop pretty quickly, and Advertising Age said advertisers could be attracted by simple novelty of the new organization.

The other big piece of the deal is the fact that it will likely mean the death of Newsweek.com, despite the fact that has a far larger audience than The Daily Beast. The website's staff members are nervously awaiting their fate, but in the meantime took to Tumblr to mount a defense of Newsweek.com, praising its work while saying it has "always remained an ugly stepchild to its print grandparents, who were too busy burning money to notice." Former Newsweek.com staffer Mark Coatney chimed in, wondering what would happen to Newsweek's SEO and content deals without its own site, Buy Glucophage No Prescription. Reuters' Felix Salmon also agreed, purchase Glucophage online, saying the shutdown only makes sense as a power grab by Brown. But Advertising Age and GigaOM defended the move, saying the Beast's traffic is more valuable than Newsweek's.

—

Don't call it an email killer: Facebook made a big announcement this week, unveiling its new quasi-email, quasi-chat message system, Online buy Glucophage without a prescription,  Facebook Messages. (Want to know what it looks like. Search Engine Land has you covered.) The message we heard repeatedly Buy Glucophage No Prescription, from Facebook was that Messages is not a rival to email services like Google's Gmail. And why was that. Well, because it spent most of the weekend being hyped as a "Gmail killer." And the reason it's such a threat to email, said Charlene Li and ReadWriteWeb, is precisely because it's a lot more than email: It's the convergence of chat, email and text messaging; archived communications by friend; and a "social inbox." The gadget blog Gizmodo said we'll be giving up traditional email for it because we're all already using Facebook's interface and because it should be able to sort what's important from what's not, Glucophage no prescription.

But another Gawker blog, Lifehacker, said we shouldn't give up email for Facebook Messages, because it's meant to work with email, not like email. In addition, Glucophage results, anything you say there can't be moved elsewhere. Others were also skeptical, for a variety of reasons: Silicon Alley Insider's Matt Rosoff and the Houston Chronicle Dwight Silverman said this isn't unified communications, but just another way to get hardcore users to spend more time on Facebook, Buy Glucophage No Prescription. GigaOM's Mathew Ingram argued that many people won't use it as an email supplement if it doesn't connect to their existing email accounts. The Guardian talked to an analyst who said Facebook can't handle the task of using all of its data to optimize social messaging. Then there's the privacy issue: Salon's Dan Gillmor said we should be uncomfortable about putting all of our communications into the hands of a single company, especially Facebook.

There were three other thoughtful perspectives on what Facebook Messages means that stood out: Om Malik of GigaOM saw Messages as a critical step for Facebook in helping us stay in touch with our most intimate friends, as opposed to the more distant "second-order" friends it's been specializing in. Buy Glucophage No Prescription, And though he was off about the shape Messages would take, Nick O'Neill of All Facebook aptly placed Messages within a long-running battle between Facebook and Google for online authority.

Finally, buy Glucophage online no prescription, in a post at the Lab, Ken Doctor called for news organizations to embrace the philosophy behind Facebook Messages: "It’s about simplification, about interconnection, about consolidation." Meanwhile, in other much-less-covered email-related news: AOL announced it's relaunching its own email service, a story TechCrunch rather comically broke last Friday. Online buying Glucophage hcl, —

Yahoo goes deeper into original content: Yahoo dived deeper into the original-content pool this week with two moves: First, it added three new blogs to its seven-month-old The Upshot, building a network of originally reported news blogs. The new sites will focus on politics, national news, and media. CNN noted that the new group is being headed by a veteran of Talking Points Memo and quoted Yahoo News head Mark Walker as describing it as Yahoo's biggest original-content push yet: "Pure aggregation will only get you so far, even if you're really good at it."

Yahoo also completed its integration of Associated Content, Glucophage brand name, the content farm it bought in May, by relaunching it as the Yahoo Contributor Network. Through the network, Yahoo plans to post at least 2,000 articles of search engine-friendly content a day, paying its 400,000 contributors a small fee upfront, followed by bonused based on pageviews, Buy Glucophage No Prescription. Kara Swisher of All Things Digital was skeptical of the plan.

—

Some eye-opening iPad stats: We got a few more pieces of data on iPad use in the past week, including some quick, interesting stats from The Wall Street Journal showing that iPad use jumps in the evening, Effects of Glucophage, while computer use drops. (Smart phone is relatively steady throughout the day.) This seems to correlate with what many have suspected about the iPad — that it's being used as more of a leisure device than phones or computers.

Business Insider had quite a few more fascinating stats from its survey of iPad owners, finding, among other things, that most iPad owners are using their iPads more than when they first got the device, 30% are using it as their primary computer, they're spending as much time with it as they are their laptops, is Glucophage safe, and about equal numbers of people use the browser and apps to read news. Poynter's Damon Kiesow isn't reading much into the data Buy Glucophage No Prescription, , but he did find it surprising that about a third are reading news primarily on apps, considering how few news orgs have them out right now. That's good news for major media outlets, he said, though it doesn't mean much for the little guys.

Meanwhile, News Corp.'s James Murdoch said he thinks news apps for mobile devices like the iPad cannibalize newspaper sales, Glucophage forum, something Reuters' Felix Salmon wasn't sure about, and Poynter's Kiesow wasn't buying without seeing some data. News Corp., by the way, is reported to be close to launching its much-talked-about tablet news publication, and The Economist dropped its own iPad app this week.

—

Google News' crediting experiment: One cool little story worth highlighting: Google News announced it's introducing two tags for articles that will help indicate which articles were the first to report a story and which articles are essentially the same story on different sites. It's an experiment, as the Lab's Megan Garber noted, in finding out how willing news organizations are to give online credit where credit is due, Buy Glucophage No Prescription. As Search Engine Land's Matt McGee pointed out, ordering Glucophage online, they're based on the honor system, so there's nothing to stop spammers (or legit news organizations) from misusing the tags. CUNY j-prof C.W. Anderson wondered if the tags might provide some new research opportunities for scholars.

—

Reading roundup: Here's everything else worth taking a look at before you hit the weekend:

— Over at the National Sports Journalism Center, Jason Fry has written a wonderful column on the importance of the link to sports journalism, and it goes for all journalism as well. Buy Glucophage No Prescription, Elsewhere, Terry Heaton wrote about the value of the link in online advertising, a notion The Batavian's Howard Owens took issue with.

— A few paid-content tidbits: Connecticut's Valley Independent Sentinel is the latest local newspaper to make use of Journalism Online's Press+ paid-content system, The Times of London is partnering with a mobile broadband provider for a free-access offer at its website, and two new-media companies are working on an online news "EZ Pass."

— A couple pieces from last week I missed: Mashable's Vadim Lavrusik and Eastern Illinois j-prof Bryan Murley both urged j-schools to push some more boundaries in their teaching of news and technology.

— Weekly fuel for the pessimists among us: Poynter's Rick Edmonds on the signs that newspapers are still failing financially, and the nonprofit news site The Washington Independent announced it's closing up shop.

— And in the food-for-thought category: Jonathan Stray on the real value of social news, and CUNY j-prof C.W. Anderson at the Lab on journalism and online community. "We can’t will authentic community into being. It sort of sneaks up on us. And just as quickly — as soon as we turn our heads — it’s gone.".

Similar posts: Synthroid Cost. Lipitor No Rx. Purchase Retin A. Glucophage from canadian pharmacy. Where can i buy cheapest Flagyl online. Glucophage photos.
Trackbacks from: Buy Glucophage No Prescription. Buy Glucophage No Prescription. Buy Glucophage No Prescription. Is Glucophage safe. Glucophage coupon. Purchase Glucophage online no prescription.